Showing results (1911-1920 of 3,159) with videos related to
Sort By:
Pageof 316
Neuro-Oncology|December 15, 2010
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?Amy B Heimberger, John H SampsonNeuro-Oncology|February 5, 2011
A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor ConsortiumIan F Pollack, Clinton F Stewart, Mehmet Kocak, et al.Neuro-Oncology|February 23, 2011
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupKenneth J Cohen, Ian F Pollack, Tianni Zhou, et al.Neuro-Oncology|February 8, 2011
MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomasXiang Liu, Wei Tian, Balasubramanya Kolar, et al.Neuro-Oncology|February 25, 2011
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology GroupKenneth J Cohen, Richard L Heideman, Tianni Zhou, et al.Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.Neuro-Oncology|December 18, 2010
Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factorMatthew Crocker, Sue Ashley, Ian Giddings, et al.Neuro-Oncology|June 10, 2011
Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapySu Guan, Ruijun Shen, Tiffany Lafortune, et al.Neuro-Oncology|December 24, 2010
First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to responseWalter Taal, Hendrikus J Dubbink, Chris B L Zonnenberg, et al.Neuro-Oncology|July 5, 2011
A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivoDavid S Ziegler, Joanna Keating, Santosh Kesari, et al.Pageof 316